sb 202190 has been researched along with Bronchial Hyperreactivity in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atherton, HC | 1 |
| Jones, G | 1 |
| Danahay, H | 1 |
| Peng, Q | 1 |
| Matsuda, T | 1 |
| Hirst, SJ | 1 |
2 other studies available for sb 202190 and Bronchial Hyperreactivity
| Article | Year |
|---|---|
IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation.
Topics: Bronchi; Bronchial Hyperreactivity; Butadienes; Cell Count; Cells, Cultured; Chromones; Enzyme Inhib | 2003 |
Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle.
Topics: Adult; Aged; Asthma; Bronchial Hyperreactivity; Butadienes; Cells, Cultured; Chemokine CCL11; Chemok | 2004 |